|
Dr. Goldberg joined the company as Vice President of Quality Assurance and Regulatory Affairs in August 2006. Dr. Goldberg has over 20 years of experience in the pharmaceutical, clinical therapy, blood fractionation and device industry, having served as a Manager of Stability, Manager of New Product Development, Director of Toxicology, Directory of Validation, Director of Quality Assurance and Regulatory Affairs and Director of Quality Control at City of Hope, Alpha Therapeutic Corporation, LifePoint Inc. and Novocell, Inc. Dr. Goldberg received his B. A. in Bacteriology from UCLA, an M. S. in Biochemistry from CSULA and a PhD in Cell Biology from UCLA. Dr. Goldberg is the author/co-author of 15 research publications and 27 toxicological reports. Dr. Goldberg is a member of the New York Academy of Sciences, Society of Toxicology, American Society of Microbiology, American Society for Quality and is listed in Who's Who (America, World and Science and Engineering). | 